前列腺素内过氧化物在不产生血栓素A2的情况下可诱导血小板聚集的证据。 - Suppr

Suppr

超能文献

Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production.

作者信息

Hornby E J, Skidmore I F

出版信息

Biochem Pharmacol. 1982 Mar 15;31(6):1158-60. doi: 10.1016/0006-2952(82)90359-8.

DOI:10.1016/0006-2952(82)90359-8

PMID:7200773

Abstract

摘要

相似文献

Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production.

Biochem Pharmacol. 1982 Mar 15;31(6):1158-60. doi: 10.1016/0006-2952(82)90359-8.

[Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].

Dokl Akad Nauk SSSR. 1985 May-Jun;282(1):194-6.

Nicotinic acid inhibits thromboxane synthesis in platelets.

Prostaglandins. 1978 Apr;15(4):629-36. doi: 10.1016/0090-6980(78)90058-8.

Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.

Prostaglandins. 1977 Nov;14(5):881-9. doi: 10.1016/0090-6980(77)90304-5.

Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.

Br J Pharmacol. 1982 Apr;75(4):623-31. doi: 10.1111/j.1476-5381.1982.tb09183.x.

The biochemical pharmacology of thromboxane synthase inhibition in man.

Circulation. 1985 Dec;72(6):1194-201. doi: 10.1161/01.cir.72.6.1194.

Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.

J Lab Clin Med. 1985 Sep;106(3):246-52.

[Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].

Biull Eksp Biol Med. 1984 Nov;98(11):563-6.

A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.

Br J Pharmacol. 1985 Feb;84(2):425-30. doi: 10.1111/j.1476-5381.1985.tb12926.x.

Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2.

Thromb Res. 1983 May 1;30(3):289-96. doi: 10.1016/0049-3848(83)90082-8.

引用本文的文献

Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: an intracellular study.

Lipids. 2004 May;39(5):433-40. doi: 10.1007/s11745-004-1248-9.

Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.

Br J Pharmacol. 2004 Sep;143(1):193-201. doi: 10.1038/sj.bjp.0705917. Epub 2004 Aug 2.

Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.

Br J Pharmacol. 2002 Dec;137(7):1082-8. doi: 10.1038/sj.bjp.0704963.

The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase.

Br J Pharmacol. 1999 Jul;127(5):1206-12. doi: 10.1038/sj.bjp.0702637.

Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo.

Br J Pharmacol. 1989 Feb;96(2):395-405. doi: 10.1111/j.1476-5381.1989.tb11830.x.

Current concepts for a drug-induced inhibition of formation and action of thromboxane A2.

Blut. 1990 May;60(5):261-8. doi: 10.1007/BF01736225.

Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.

Br J Pharmacol. 1991 Feb;102(2):497-505. doi: 10.1111/j.1476-5381.1991.tb12200.x.

Thromboxane synthase inhibitors and receptor antagonists.

Cardiovasc Drugs Ther. 1992 Feb;6(1):29-33. doi: 10.1007/BF00050914.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验